Stockscreener 앱 받기
62.55
5.49%
-3.63
시장 영업 전:
63.81
1.26
+2.01%
전일 마감가:
$66.18
열려 있는:
$64.57
하루 거래량:
26.66M
Relative Volume:
0.57
시가총액:
$13.48B
수익:
$1.78B
순이익/손실:
$164.40M
주가수익비율:
90.65
EPS:
0.69
순현금흐름:
$236.51M
1주 성능:
+8.50%
1개월 성능:
+30.42%
6개월 성능:
+67.78%
1년 성능:
+237.93%
1일 변동 폭
$61.69
$66.20
1주일 범위
$56.10
$70.43
52주 변동 폭
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
명칭
Hims Hers Health Inc
전화
415-851-0195
주소
2269 CHESTNUT ST, SAN FRANCISCO
HIMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
62.55 | 14.81B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
150.65 | 352.40B | 84.28B | 15.97B | 14.04B | 6.51 |
|
UL
Unilever Plc Adr
|
60.47 | 143.26B | 65.76B | 6.16B | 0 | 2.4843 |
|
CL
Colgate Palmolive Co
|
83.51 | 67.95B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KMB
Kimberly Clark Corp
|
130.64 | 41.35B | 18.88B | 2.43B | 2.10B | 7.26 |
|
KVUE
Kenvue Inc
|
21.59 | 41.16B | 15.30B | 1.06B | 1.45B | 0.55 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-23 | 다운그레이드 | Needham | Buy → Hold |
| 2025-06-04 | 재확인 | Needham | Buy |
| 2025-04-29 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-01-07 | 개시 | BTIG Research | Buy |
| 2024-12-17 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-08-22 | 개시 | Needham | Buy |
| 2024-08-09 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-04-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-04-10 | 개시 | Canaccord Genuity | Buy |
| 2024-02-28 | 업그레이드 | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | Imperial Capital | In-line |
| 2023-07-28 | 개시 | TD Cowen | Outperform |
| 2023-04-11 | 개시 | Robert W. Baird | Neutral |
| 2023-02-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-08 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-07-15 | 개시 | SVB Leerink | Underperform |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-10 | 개시 | Deutsche Bank | Hold |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-11-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 개시 | BofA Securities | Neutral |
| 2021-05-20 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 개시 | Truist | Hold |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-03-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 개시 | Citigroup | Neutral |
| 2021-02-12 | 개시 | Piper Sandler | Neutral |
| 2021-02-08 | 개시 | Tigress Financial | Buy |
모두보기
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Levi & Korsinsky Notifies Hims & Hers Health, Inc. (HIMS) Shareholders of Class Action Lawsuit and August 25, 2025 Deadline - ACCESS Newswire
2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run - The Motley Fool
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - MarketScreener
HIMS Investors Have Opportunity To Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - Barchart.com
INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - GlobeNewswire Inc.
HIMS Investors Have the Opportunity to Lead the Hims Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar
What To Expect From Hims & Hers Health’s (HIMS) Q2 Earnings - FinancialContent
HIMS ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
Kessler Topaz Meltzer & Check, LLPHIMS Investor Alert: A - GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Hims & - GlobeNewswire
HIMS INVESTOR REMINDER: Hims & Hers Health, Inc. Stock Drop - GlobeNewswire
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims - Barchart.com
HIMS LAWSUIT ALERT: Levi & Korsinsky Notifies Hims & Hers Health, Inc. InvestorsLead Plaintiff Deadline August 25, 2025 - ACCESS Newswire
Will Hims & Hers Fall Along With Novo Nordisk? - MarketBeat
Hims & Hers Health, Inc. (HIMS) – Lawmakers Urge Crackdown - GlobeNewswire
Lead Plaintiff Deadline on August 25, 2025 for HIMS InvestorsKessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm - PR Newswire
Hims & Hers Stock to Report Q2 Earnings: What's in the Cards? - Yahoo Finance
Kimberly-Clark, Hims & Hers Health, CNH Industrial - TradingView
How Will Hims & Hers Health Stock React To Its Upcoming Earnings? - Trefis
Hims & Hers Health: A Glimmer of Innovation or a Fleeting Fad? - AInvest
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Hims & Hers Stock Up, Nearing All-Time High As Weight-Loss Giants Stumble - Benzinga
Shareholders of Hims & Hers Health, Inc. (HIMS): Protect Your Rights Before August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare - Yahoo Finance
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - MarketScreener
HIMS INVESTORS: Hims & Hers Health, Inc. (NYSE:HIMS) - GlobeNewswire
The Gross Law Firm Notifies Hims & Hers Health, Inc. - GlobeNewswire
Investor Alert: Deadline Approaching to Join Hims & Hers Health, Inc. (HIMS) Class ActionContact Levi & Korsinsky - ACCESS Newswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Hims & Hers - GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) Alleged “Deceptive” - GlobeNewswire
Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings? - Yahoo Finance
Hims & Hers Health Closes In On Buy Point As Earnings Loom - Investor's Business Daily
DEADLINE ALERT for RDDT, HIMS, IRBT, and CNC: The Law - GlobeNewswire
Hims & Hers Health CLO Sells $150K in Shares as Stock Climbs After Tumultuous Month | HIMS Stock - paginasiete.bo
Hims Stock Rises 12% Amid Strategic Innovations and Retail Investor Interest - AInvest
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Novo Nordisk Charts Signal Weakness Amid Wegovy Warning, Expert Says 'Could've Played Out VERY Differently If They Had Embraced $HIMS' - Benzinga
Securities Fraud Class Action Filed Against Hims & Hers Health, Inc. (HIMS)Levi & Korsinsky Reminds Investors of August 25, 2025 - ACCESS Newswire
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - GlobeNewswire Inc.
Soleil Boughton, Hims & Hers health CLO, sells $150k in stock - Investing.com Nigeria
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors - GlobeNewswire
Hims & Hers stock pares losses on data despite Novo Nordisk litigation fears - Investing.com Canada
Hims & Hers stock pares losses on data despite Novo Nordisk litigation fears By Investing.com - Investing.com South Africa
Hims & Hers reports 10.3% weight loss in customers using GLP-1 treatments - Investing.com Canada
Hims Hers Health Inc (HIMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.96%
0.26%
자본화:
|
볼륨(24시간):